Navigation Links
Dragon Pharma announces 2007 full year financial results
Date:3/31/2008

margin has risen to -9.4% in 2007 compared to -12.8% in 2006.

The total operating expenses were $10.9 million in 2007 as compared to $7.7 million in 2006. The increase reflects an increase of the non-cash stock-based compensation expense and consulting fees related to Sarbanes-Oxley compliance and increased selling expenses due to an increase in sales in both the Chemical and Pharma Divisions.

As a result of the strong sales growth as well as the improved margins for both divisions, the Company realized an after-tax income from continuing operations of $4.9 million for 2007 as compared to an after-tax loss from continuing operation of $0.9 million for the year of 2006. The Company also recognized an after-tax loss from discontinued operations of $2.40 million, which was mainly due to the impact of a non-cash write-off of $3.11 million of intangible assets and goodwill with the sales of the Biotech Division. The net income was $2.50 million or $0.04 per share, which was the net of $4.9 million or $0.08 per share net income from continuing operations and $2.40 million or $0.04 per share net loss from discontinued operations.

"2007 has been an extremely positive year for Dragon Pharma," said Dragon's Chairman and CEO Mr. Yanlin Han. "The Company's solid year-over-year growth demonstrates our effectiveness and capabilities in executing our core business strategy. To achieve our goal to become a leading vertically integrated antibiotic drugs manufacturer, we will continuously broaden our product portfolio, expand market share, lower production cost by incorporating innovative technology, improve manufacturing process and efficiencies, strengthen our management team and enhance R&D capability. In early 2008, the Company has successfully launched two new products ceflazidime and cefalexin. With the expansion of our product portfolio alongside increased annual production capacity for our core products 7-ACA and Clavulanic Acid, we are confident in our a
'/>"/>

SOURCE Dragon Pharmaceutical Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Dragon retains leading investor relations firm
2. Dragon announces new product launch; increase in annual production output capacity
3. Dragon Announces R&D Achievement in Biotech Manufacturing Process
4. Strong Demand Pushes up Both Prices and Sales Volumes for Dragons Main Products
5. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
6. Transgenomic Opens Pharmacogenomics Laboratory in China
7. PharmAthene Reports Year-End 2007 Financial Results
8. Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights
9. China Pharma Holdings, Inc. Announces Record 2007 Year End Results
10. Huifeng Bio-Pharmaceutical (HFGB) Announces 2007 Full Year Results
11. Eisai is Granted Favorable Preliminary Injunction Ruling in Aricept(R) Patent Infringement Lawsuit Against Teva Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... England , May 24, 2013 ... Mundipharma angefertigt – Bei der ... , 91 % der Teilnehmer einer groß ... nur 20 % laut GINA [*] -Definition [1] ... dass Menschen mit Asthma generell einer von vier Denkweisen ...
(Date:5/23/2013)... ELMSFORD, N.Y. , May 23, 2013  BioScrip, ... the Company will present at the Jefferies 2013 Global ... the Grand Hyatt New York. ... and Hai Tran , Chief Financial ... 11:30 a.m. Eastern Daylight Time.   About ...
(Date:5/23/2013)... Patheon Inc ., a leading provider ... pharmaceutical industry, will host a complimentary webinar on “Cleaning ... Tuesday, June 4, 2013 at 11 a.m. Eastern Standard ... comply with regulations for cleaning validation. Many companies ... and little evaluation of risk. Some companies have ...
(Date:5/23/2013)... Francisco, CA (PRWEB) May 23, 2013 ... who encourage all types of inventions. They focus on ... now noticing this community gravitate toward bringing their ideas ... the DIY Biology Movement, works on making projects using ... the DNA of plants to make them glow with ...
Breaking Biology Technology:Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 2Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 3Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 4Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 5Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 6Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 7Patheon to Present on “Cleaning Validation: Science, Risk and Novel Approaches to Testing” 2Glowing Plant Releases Maker Kit, Enabling Anyone to Make a Glowing Plant at Home 2
... may inadequately stimulate a patient,s heart while undergoing a ... pulses mixing with the electronic pulses from the pacemaker. ... patient undergoing the MRI scan, according to research published ... Online . MRI is an imaging technique that ...
... the Nanyang Technological University (NTU) signed the Memorandum of ... Research (CNRS) and the Thales Group of Companies to ... are meeting again in Singapore to inaugurate the CNRS-International-NTU-Thales ... at the Research Techno Plaza, the CINTRA Laboratory aims ...
... FREMONT, Calif., Dec. 16 WaferGen Biosystems, Inc. (OTC ... analysis systems, today announced that it will be launching ... gene-expression profiling using its SmartChip(TM) Real-Time PCR System. ... microRNA panel of 885 microRNAs on a single SmartChip. ...
Cached Biology Technology:FDA researchers identify new MRI safety risk for patients with pacemakers 2New Singapore-French nanotech lab opens at NTU 2New Singapore-French nanotech lab opens at NTU 3WaferGen to Launch Human MicroRNA Panel for Gene-Expression Profiling of 885 MicroRNA for Its Service Using the SmartChip(TM) Real-Time PCR System 2WaferGen to Launch Human MicroRNA Panel for Gene-Expression Profiling of 885 MicroRNA for Its Service Using the SmartChip(TM) Real-Time PCR System 3WaferGen to Launch Human MicroRNA Panel for Gene-Expression Profiling of 885 MicroRNA for Its Service Using the SmartChip(TM) Real-Time PCR System 4
(Date:5/23/2013)... cancer patients unnecessarily undergo surgery or harsh treatments ... slow-growing and aggressive forms of the disease. Researchers ... Medical Institutes are developing technology that allows patients ... relatively mild treatments or take drastic measures. , ... an associate professor of biomedical engineering at Case ...
(Date:5/23/2013)... in treating cerebral palsy with autologous cord blood. Following ... year old boy had been in a persistent vegetative ... months after treatment with the cord blood containing stem ... the child learned to speak simple sentences and to ... study, dispel the long-held doubts about the effectiveness of ...
(Date:5/23/2013)... and fastest growing open-access publishers, announces the launch ... and Biotechnology . , A broad scope ... and Biotechnology will provide a single open-access ... research to be disseminated and discussed. , ... provide an open-science and interactive web platform for ...
Breaking Biology News(10 mins):Using big data to identify prostate cancers and best treatments 2Using big data to identify prostate cancers and best treatments 3First successful treatment of pediatric cerebral palsy with autologous cord blood 2Frontiers launches new open-access journal in Bioengineering and Biotechnology 2
... Researchers at King,s College London have discovered how coral ... UV rays, leading scientists to believe these compounds could ... for humans. , The team has begun to uncover ... are produced and eventually hope to recreate them synthetically ...
... From medicine and food to energy and agriculture, ... to the challenges faced by societies in the 21st ... development of gluten-free wheat, could bring hope to those ... the world population nears seven billion people, biotechnology plays ...
... and the Child & Family Research Institute have shown that ... imprint on their sons, or daughters, genes an imprint ... are expressed later in life. The study, published online ... epigenetics the expression of genes as opposed to the ...
Cached Biology News:Tropical coral could be used to create novel sunscreens for human use, say scientists 2Tropical coral could be used to create novel sunscreens for human use, say scientists 3Parents' stress leaves lasting marks on children’s genes: UBC-CFRI research 2
Sheep polyclonal to ErbB 2 ( Abpromise for all tested applications). Antigen: Recombinant full length c-ErbB2 protein (Human). Entrez GeneID: 2064 Swiss Protein ID: P04626...
200 μg per ml DNA in 10 SSPE, 2 Denhardt's...
Anti-Potassium Channel Kv2.2 Immunogen: Synthetic peptide from rat Kv2.2. Available Date: 38376...
MagSi uniform silica particles coated with a carboxyl group containing polymer, covalently attached to the bead surface....
Biology Products: